Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Warrants Expiration Dates per Q2 M&D

<< Previous

Bullboard Posts

Next >>

Post by 99942Apophison Sep 22, 2022 8:33am

469 Views

Post# 34978479

Warrants Expiration Dates per Q2 M&D

As of August 29, 2022, there were 64,759,165 warrants outstanding. Each whole warrant entitles the holder thereof to purchase one additional common share.
The warrants are exercisable as follows: 3,165,008 at a price of $0.50 until October 3, 2022, 4,095,157 at a price of $0.50 until January 9, 2023, and 57,499,000 at a price of $0.35 until August 22, 2024.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project